Roflumilast

ATC R03DX07 · 7 markets · 60 records

Roflumilast 7 markets · 60 records Forms

US 33 records · 5 strengths

0.5 mgtabletDaliresp+1__no_trade__ also in CA·ES
0.25 mgtabletDaliresp+1__no_trade__ also in ES
3 mgtopicalZORYVE
1.5 mgtopicalZORYVE
0.5 mgtopicalZORYVE

GB 8 records · 1 strengths

Records without a stated strength · 1 Daxas 250microgram tablets、Daxas 500microgram tablets、__no_trade__

CA 5 records · 4 strengths

0.5 mgtabletDAXAS also in US·ES
0.3 %topicalZORYVE
0.15 %topicalZORYVE
0.05 %topicalZORYVE

ES 4 records · 3 strengths

0.5 mgtabletROFLUMILAST AUROVITAS also in US·CA
0.25 mgtabletDAXAS+1ROFLUMILAST AUROVITAS also in US
500 mgtabletDAXAS

HK 2 records · 1 strengths

Records without a stated strength · 1 DAXAS、ROFMILAS TABLETS 500MCG

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 DAXAS

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.